Literature DB >> 2498261

The effects of vincristine and doxorubicin on the clonogenic cells of a human lung cancer cell line in methylcellulose and suspension culture.

Y Yamashita1, N Nara, N Aoki.   

Abstract

The effects of vincristine (VCR) and doxorubicin (DOX) on the growth of an established line of human lung cancer cells, PC9, were studied in methylcellulose and suspension cultures. The secondary colony formation in methylcellulose and recovery of clonogenic cells in suspension were considered to reflect well the self-renewal of the clonogenic cells. When dose-response curves were obtained for VCR and DOX, the primary clonogenic cells (PE1) were more sensitive than secondary clonogenic cells (PE2) or clonogenic cells in suspension. Repeated exposure to VCR in suspension did not inhibit the exponential growth of the clonogenic cells. These data indicated that both drugs were relatively ineffective in specifically suppressing the self-renewal of the clonogenic cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2498261      PMCID: PMC5917725          DOI: 10.1111/j.1349-7006.1989.tb02305.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  18 in total

1.  Antitumor effect of two-drug simultaneous or sequential use of cisplatin, vindesine or etoposide on human pulmonary adenocarcinoma cell lines in tumor clonogenic assay.

Authors:  Y C Lee; N Saijo; Y Sasaki; H Takahashi; M Sakurai; J Ishihara; T Sano; A Hoshi; K M Chen; A W Hamburger
Journal:  Jpn J Cancer Res       Date:  1986-03

2.  Relationship between the in vitro sensitivity to cytosine arabinoside of blast progenitors and the outcome of treatment in acute myeloblastic leukaemia patients.

Authors:  N Nara; T Suzuki; K Nagata; Y Yamashita; I Murohashi; Y Adachi
Journal:  Br J Haematol       Date:  1988-10       Impact factor: 6.998

3.  Self-renewal in culture of proliferative blast progenitor cells in acute myeloblastic leukemia.

Authors:  R N Buick; M D Minden; E A McCulloch
Journal:  Blood       Date:  1979-07       Impact factor: 22.113

4.  A stem cell model of human tumor growth: implications for tumor cell clonogenic assays.

Authors:  W J Mackillop; A Ciampi; J E Till; R N Buick
Journal:  J Natl Cancer Inst       Date:  1983-01       Impact factor: 13.506

5.  Cytotoxicity of 4-hydroperoxycyclophosphamide for the blast progenitors of acute myeloblastic leukemia.

Authors:  N Nara; T Suzuki; Y Yamashita; I Murohashi; N Aoki
Journal:  Cancer Res       Date:  1988-05-01       Impact factor: 12.701

6.  The proliferation in suspension of the progenitors of the blast cells in acute myeloblastic leukemia.

Authors:  N Nara; E A McCulloch
Journal:  Blood       Date:  1985-06       Impact factor: 22.113

7.  Prospective clinical trial of a human tumor cloning system.

Authors:  D D Von Hoff; G M Clark; B J Stogdill; M F Sarosdy; M T O'Brien; J T Casper; D E Mattox; C P Page; A B Cruz; J F Sandbach
Journal:  Cancer Res       Date:  1983-04       Impact factor: 12.701

8.  The sensitivity to cytosine arabinoside of the blast progenitors of acute myeloblastic leukemia.

Authors:  N Nara; J E Curtis; J S Senn; D L Tritchler; E A McCulloch
Journal:  Blood       Date:  1986-03       Impact factor: 22.113

9.  Comparative effects of vinca alkaloids (VCR, VDS) and epipodophyllotoxin (VP16) on murine myeloblastic leukaemia.

Authors:  Y Yamashita; N Nara; I Murohashi; Y Imai; N Aoki
Journal:  Br J Cancer       Date:  1987-05       Impact factor: 7.640

10.  Measurement of self-renewal in culture of clonogenic cells from human ovarian carcinoma.

Authors:  R N Buick; W J MacKillop
Journal:  Br J Cancer       Date:  1981-09       Impact factor: 7.640

View more
  1 in total

1.  Effects of the ACTH(4-9) analogue, ORG 2766, on vincristine cytotoxicity in two human lymphoma cell lines, U937 and U715.

Authors:  B Kiburg; A A van de Loosdrecht; K M Schweitzer; G J Ossenkoppele; L J Müller; J J Heimans; P C Huijgens
Journal:  Br J Cancer       Date:  1994-03       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.